Vitamin D
In clinical developmentAlso known as Calciferol, Calciotropic hormone, D Vitamin, Vit.D+4 more
Calciferol, Calciotropic hormone, D Vitamin, Vit.D, Vitamin D NOS, Vitamin D, unspecified form, Vitamin-D, Vitamin D and/or vitamin D derivative.
Recent clinical, regulatory, research and industry developments relating to this drug.
Study challenges a common belief about vitamin D and sunlight
Study challenges a common belief about vitamin D and sunlight
Scientists warn popular vitamin D supplement may have a “previously unknown” downside
Scientists discover strange link between vitamin D and pain
Regime for Vitamin D Maintenance in Post-Operative Patients (D-ECISIVE) Randomized Controlled Trial
Molecular Insight into the Role of Vitamin D in Immune-Mediated Inflammatory Diseases.
Evidence confidence
How strongly the incorporated evidence supports specific clinical claims about this treatment. A confidence figure is a current summary of evidence strength, not a permanent verdict.
High point estimate, but substantial uncertainty remains.
— 1 supporting evidence family · 1 well-powered no-effect result
Confidence is moderated by well-powered no-effect evidence and limited publication incorporation.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Can Vitamin D Supplementation Prevent Food Allergy in Infants? The VITALITY Trial
Recent completions
Trials that read out recently, adding to the completed evidence base.
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Nutrients10
- International journal of molecular sciences7
- Frontiers in endocrinology2
- The Journal of clinical investigation2
- Acta dermato-venereologica1
- Andrology1
- Bechter O3
- Bennett GG3
- Boecxstaens V3
- Bogaerts K3
- Chan AT3
- Chandler PD3
- De Smedt J3
- Drake BF3
- Brigham and Women's Hospital3
- Clinical and Experimental Endocrinology2
- College of Human Ecology2
- Conway Institute of Biomolecular and Biomedical Research2
- Laboratory for Translational Genetics2
- Laboratory of Dermatology2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Acts on the same molecular target as Vitamin D, with 9 overlapping disease areas.
Studied across 17 of the same disease areas as Vitamin D in the shared literature.
Studied across 17 of the same disease areas as Vitamin D in the shared literature.
Studied across 12 of the same disease areas as Vitamin D in the shared literature.
Studied across 14 of the same disease areas as Vitamin D in the shared literature.
Studied across 11 of the same disease areas as Vitamin D in the shared literature.
Studied across 7 of the same disease areas as Vitamin D in the shared literature.
Studied across 7 of the same disease areas as Vitamin D in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials